ANI Pharmaceuticals Inc (ANIP)

Current ratio

		Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Total current assets	US$ in thousands	519,816	344,261	321,775	170,321	187,695
Total current liabilities	US$ in thousands	145,477	99,439	87,537	78,565	61,676
Current ratio		3.57	3.46	3.68	2.17	3.04

December 31, 2023 calculation

Current ratio = Total current assets ÷ Total current liabilities
= $519,816K ÷ $145,477K
= 3.57

The current ratio of ANI Pharmaceuticals Inc has shown a fluctuating trend over the past five years. The company's current ratio was 3.57 as of December 31, 2023, indicating that the company had $3.57 in current assets for every $1 of current liabilities. This suggests that ANI Pharmaceuticals Inc had a strong ability to cover its short-term obligations in the most recent period.

Comparing this to the previous years, the company's current ratio was 3.46 in 2022, 3.68 in 2021, 2.17 in 2020, and 3.04 in 2019. The significant increase in the current ratio from 2020 to 2021 indicates an improvement in the company's liquidity position, potentially due to increased current assets or a decrease in current liabilities during that period.

ANI Pharmaceuticals Inc's current ratio has generally been above 2 over the past five years, suggesting a healthy liquidity position overall. However, it is important to note the fluctuation in the current ratio, particularly in 2020 when it dropped to 2.17, which could signal a potential liquidity challenge during that year.

In summary, ANI Pharmaceuticals Inc's current ratio of 3.57 as of December 31, 2023, indicates a strong liquidity position, but investors and stakeholders should continue to monitor the trend in the company's current ratio over time to ensure its ability to meet short-term obligations remains stable.